Organovo Holdings, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
MRNAModerna, Inc. 5.03%58.330.0%$1736.36m
GILDGilead Sciences, Inc. -0.33%75.081.0%$1314.22m
REGNRegeneron Pharmaceuticals, Inc. 0.37%580.342.5%$964.89m
AMGNAmgen, Inc. -0.27%223.541.3%$644.63m
NVAXNovavax, Inc. 0.20%44.93102.0%$580.89m
VRTXVertex Pharmaceuticals, Inc. 0.12%277.721.9%$545.37m
BIIBBiogen, Inc. 0.00%300.491.6%$410.38m
ILMNIllumina, Inc. -1.82%366.223.5%$382.10m
SRNESorrento Therapeutics, Inc. 0.20%4.961.8%$298.30m
ALXNAlexion Pharmaceuticals, Inc. 1.67%116.332.0%$269.48m
SGENSeattle Genetics, Inc. -0.19%151.276.1%$254.03m
AAgilent Technologies, Inc. 0.58%87.191.6%$200.66m
BMRNBioMarin Pharmaceutical, Inc. -1.49%104.034.3%$177.10m
CODXCo-Diagnostics, Inc. -0.46%17.390.0%$170.08m
INCYIncyte Corp. -0.53%100.022.5%$156.66m

Company Profile

Organovo Holdings, Inc. engages in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.